Regulation, Policy, Governance
How policymakers can best regulate AI to balance innovation with public interests and human rights.
HAI & AI Governance Lab | A Conversation with Jacob Coxon & Rob Reich
This in-person event is open to current Stanford faculty, students, and staff. ID will be required at check in. Other guests are invited to join the webinar.
This in-person event is open to current Stanford faculty, students, and staff. ID will be required at check in. Other guests are invited to join the webinar.
It's one of AI policy's hardest unsolved problems. Expert Deb Raji joins Stanford HAI to find answers that move beyond principles and into practice.
It's one of AI policy's hardest unsolved problems. Expert Deb Raji joins Stanford HAI to find answers that move beyond principles and into practice.
In January 2026, Utah announced a first-of-its kind pilot program allowing an autonomous artificial intelligence (AI) agent to renew prescriptions for consumers who request it. The state agreed not to enforce its unprofessional conduct laws against the developer, Doctronic, if the company adheres to a contract that includes safety and privacy protections. The pilot program includes 192 drugs for chronic conditions. Although physicians will initially validate the AI’s actions, the pilot program will swiftly become one of the first deployments at scale of an autonomous, agentic system in medicine. The announcement prompted concern from associations of physicians and pharmacists who opined that AI “should NOT be making care decisions.”
In January 2026, Utah announced a first-of-its kind pilot program allowing an autonomous artificial intelligence (AI) agent to renew prescriptions for consumers who request it. The state agreed not to enforce its unprofessional conduct laws against the developer, Doctronic, if the company adheres to a contract that includes safety and privacy protections. The pilot program includes 192 drugs for chronic conditions. Although physicians will initially validate the AI’s actions, the pilot program will swiftly become one of the first deployments at scale of an autonomous, agentic system in medicine. The announcement prompted concern from associations of physicians and pharmacists who opined that AI “should NOT be making care decisions.”
We welcome proposals for research projects that tackle important challenges and opportunities in this space from either a technical or social science perspective, with findings that can generate policy insights and recommendations.
Policy Research Grants
We welcome proposals for research projects that tackle important challenges and opportunities in this space from either a technical or social science perspective, with findings that can generate policy insights and recommendations.
Response to FDA’s Request for Feedback on Considerations for the Regulation of GenAI-Enabled Medical Devices
Stanford scholars respond to a federal request for feedback, offering policy recommendations for the regulation of generative AI-enabled medical devices.
Stanford scholars respond to a federal request for feedback, offering policy recommendations for the regulation of generative AI-enabled medical devices.
All Work Published on Regulation, Policy, Governance
In a new series called Prompt Response, Stanford’s Surya Ganguli, Diyi Yang and Rob Reich examined emergent agent behavior, recursive self-improvement, independent evaluation and whether a kill switch can make advanced AI safer.
In a new series called Prompt Response, Stanford’s Surya Ganguli, Diyi Yang and Rob Reich examined emergent agent behavior, recursive self-improvement, independent evaluation and whether a kill switch can make advanced AI safer.
The AI Arms Race In Health Insurance Utilization Review: Promises Of Efficiency And Risks Of Supercharged Flaws
Health insurers and health care provider organizations are increasingly using artificial intelligence (AI) tools in prior authorization and claims processes. AI offers many potential benefits, but its adoption has raised concerns about the role of the “humans in the loop,” users’ understanding of AI, opacity of algorithmic determinations, underperformance in certain tasks, automation bias, and unintended social consequences. To date, institutional governance by insurers and providers has not fully met the challenge of ensuring responsible use. However, several steps could be taken to help realize the benefits of AI use while minimizing risks. Drawing on empirical work on AI use and our own ethical assessments of provider-facing tools as part of the AI governance process at Stanford Health Care, we examine why utilization review has attracted so much AI innovation and why it is challenging to ensure responsible use of AI. We conclude with several steps that could be taken to help realize the benefits of AI use while minimizing risks.
Health insurers and health care provider organizations are increasingly using artificial intelligence (AI) tools in prior authorization and claims processes. AI offers many potential benefits, but its adoption has raised concerns about the role of the “humans in the loop,” users’ understanding of AI, opacity of algorithmic determinations, underperformance in certain tasks, automation bias, and unintended social consequences. To date, institutional governance by insurers and providers has not fully met the challenge of ensuring responsible use. However, several steps could be taken to help realize the benefits of AI use while minimizing risks. Drawing on empirical work on AI use and our own ethical assessments of provider-facing tools as part of the AI governance process at Stanford Health Care, we examine why utilization review has attracted so much AI innovation and why it is challenging to ensure responsible use of AI. We conclude with several steps that could be taken to help realize the benefits of AI use while minimizing risks.
Implementing the Transparency in Frontier AI Act Report for the California Department of Technology Multistakeholder Workshops
In this paper, HAI Associate Director and Senior Fellow Rob Reich and UC Berkeley School of Information Professor Deirdre K. Mulligan provide concrete recommendations to the California Department of Technology on the implementation of its frontier AI transparency requirements.
In this paper, HAI Associate Director and Senior Fellow Rob Reich and UC Berkeley School of Information Professor Deirdre K. Mulligan provide concrete recommendations to the California Department of Technology on the implementation of its frontier AI transparency requirements.
Julian Nyarko
HAI Denning Director James Landay responds to the latest round of AI doomerism and how policymakers should respond to it.
HAI Denning Director James Landay responds to the latest round of AI doomerism and how policymakers should respond to it.